Suvretta Capital Management 13F holdings, Q2 2024
Holdings as of June 30, 2024 · filings on SEC EDGAR · latest filing →
Suvretta Capital Management disclosed 97 US equity positions worth $2.5bn in its Q2 2024 13F filing. The largest position was BHVN at 7.4% of the reported book, followed by INSM and KURA. Against the Q1 2024 filing, it opened 7 new positions, added to 23 and reduced 11 among the top 50 holdings.
What did Suvretta Capital Management own in Q2 2024? Top 50 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q1 2024 |
|---|---|---|---|---|---|---|---|
| 1 | BHVN BIOHAVEN LTD | Healthcare | 7.4% | $180.5m | 5,199,219 | 30% | added |
| 2 | INSM INSMED INC | Healthcare | 6.9% | $169.0m | 2,521,800 | 25% | added |
| 3 | KURA KURA ONCOLOGY INC | Healthcare | 5.9% | $145.6m | 7,069,627 | 0% | held |
| 4 | INTRA-CELLULAR THERAPIES INC | 4.4% | $107.3m | 1,565,996 | 63% | added | |
| 5 | ARQT ARCUTIS BIOTHERAPEUTICS INC | Healthcare | 3.8% | $93.0m | 10,004,492 | 27% | added |
| 6 | RARE ULTRAGENYX PHARMACEUTICAL IN | Healthcare | 3.5% | $84.7m | 2,061,426 | 23% | added |
| 7 | META META PLATFORMS INC | Communication Services | 3.4% | $84.3m | 167,169 | -4% | reduced |
| 8 | ARCELLX INC | 3.4% | $83.7m | 1,516,254 | -3% | reduced | |
| 9 | UNH UNITEDHEALTH GROUP INC | Healthcare | 3.4% | $82.2m | 161,468 | 968% | added |
| 10 | AAPL APPLE INC | Technology | 3.1% | $76.5m | 363,357 | 106% | added |
| 11 | AMZN AMAZON COM INC | Consumer Cyclical | 2.8% | $68.8m | 356,268 | -0% | held |
| 12 | 89BIO INC | 2.6% | $64.3m | 8,031,845 | 28% | added | |
| 13 | TSM TAIWAN SEMICONDUCTOR MFG LTD | Technology | 2.5% | $61.0m | 350,752 | 6% | added |
| 14 | AMD ADVANCED MICRO DEVICES INC | Technology | 2.3% | $56.1m | 345,998 | 1% | added |
| 15 | ELV ELEVANCE HEALTH INC | Healthcare | 2.0% | $49.5m | 91,442 | 80% | added |
| 16 | 4XC1 KALVISTA PHARMACEUTICALS INC | 2.0% | $49.4m | 4,192,005 | 0% | held | |
| 17 | RPRX ROYALTY PHARMA PLC | Healthcare | 2.0% | $49.2m | 1,866,361 | -17% | reduced |
| 18 | MSFT MICROSOFT CORP | Technology | 1.9% | $46.5m | 104,033 | 31% | added |
| 19 | EYPT EYEPOINT PHARMACEUTICALS INC | Healthcare | 1.8% | $45.0m | 5,175,823 | 38% | added |
| 20 | APO APOLLO GLOBAL MGMT INC | Financial Services | 1.7% | $41.9m | 354,486 | -4% | reduced |
| 21 | T AT&T INC | Communication Services | 1.7% | $41.8m | 2,186,886 | -9% | reduced |
| 22 | SYY SYSCO CORP | Consumer Defensive | 1.5% | $37.2m | 520,900 | – | new |
| 23 | CTNM CONTINEUM THERAPEUTICS INC | 1.5% | $36.2m | 2,053,334 | – | new | |
| 24 | KO COCA COLA CO | Consumer Defensive | 1.5% | $35.7m | 560,613 | 3% | added |
| 25 | GS GOLDMAN SACHS GROUP INC | Financial Services | 1.4% | $35.3m | 77,948 | -29% | reduced |
| 26 | ORCL ORACLE CORP | Technology | 1.4% | $34.6m | 245,114 | 25% | added |
| 27 | GE GE AEROSPACE | Industrials | 1.3% | $32.6m | 204,957 | -1% | reduced |
| 28 | ERAS ERASCA INC | Healthcare | 1.3% | $32.5m | 13,768,039 | – | new |
| 29 | CRH CRH PLC | Basic Materials | 1.3% | $32.4m | 431,984 | 29% | added |
| 30 | AVBP ARRIVENT BIOPHARMA INC | 1.3% | $31.8m | 1,712,703 | 10% | added | |
| 31 | MCD MCDONALDS CORP | Consumer Cyclical | 1.1% | $28.1m | 110,434 | – | new |
| 32 | FERGUSON PLC NEW | 1.1% | $28.1m | 145,040 | -14% | reduced | |
| 33 | TSLA TESLA INC | Consumer Cyclical | 1.1% | $26.7m | 134,913 | – | new |
| 34 | VZ VERIZON COMMUNICATIONS INC | Communication Services | 1.0% | $25.2m | 609,904 | -48% | reduced |
| 35 | CMG CHIPOTLE MEXICAN GRILL INC | Consumer Cyclical | 1.0% | $25.0m | 398,500 | 4900% | added |
| 36 | PEPG PEPGEN INC | Healthcare | 1.0% | $24.3m | 1,520,932 | 0% | held |
| 37 | PROK PROKIDNEY CORP | 0.9% | $23.0m | 9,341,266 | 142% | added | |
| 38 | STRO SUTRO BIOPHARMA INC | Healthcare | 0.9% | $22.6m | 7,708,690 | 33% | added |
| 39 | BSX BOSTON SCIENTIFIC CORP | Healthcare | 0.8% | $19.4m | 251,689 | -17% | reduced |
| 40 | PINS PINTEREST INC | Communication Services | 0.7% | $18.1m | 409,951 | 4% | added |
| 41 | ZURA ZURA BIO LTD | Healthcare | 0.7% | $17.0m | 4,860,939 | 71% | added |
| 42 | FULC FULCRUM THERAPEUTICS INC | Healthcare | 0.6% | $15.8m | 2,541,046 | -11% | reduced |
| 43 | ABEO ABEONA THERAPEUTICS INC | Healthcare | 0.6% | $15.6m | 3,685,503 | – | new |
| 44 | RCUS ARCUS BIOSCIENCES INC | Healthcare | 0.6% | $14.6m | 957,304 | 0% | held |
| 45 | JNJ JOHNSON & JOHNSON | Healthcare | 0.5% | $13.2m | 90,097 | 0% | held |
| 46 | BENITEC BIOPHARMA INC | 0.5% | $11.8m | 1,691,290 | 728% | added | |
| 47 | IMTX IMMATICS N.V | Healthcare | 0.4% | $11.0m | 946,563 | 0% | held |
| 48 | SNY SANOFI | 0.4% | $10.2m | 210,701 | 0% | held | |
| 49 | INFLARX NV | 0.4% | $10.0m | 5,733,910 | 0% | held | |
| 50 | GLUE MONTE ROSA THERAPEUTICS INC | 0.4% | $9.9m | 2,659,000 | – | new |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.